MARIBEL AGUILERA: Open Payments
NPI 1659343283 · MIAMI LAKES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$11,484 in 81 payments from 16 companies in 2025. Trend: 2023 $24,582 · 2024 $20,561 · 2025 $11,484
Speaker / faculty: $9,375Food & beverage: $2,109
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $9,872 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $293 |
| Almatica Pharma LLC | 7 | $199 |
| Vanda Pharmaceuticals Inc. | 7 | $192 |
| Lundbeck LLC | 6 | $139 |
| Axsome Therapeutics, Inc. | 5 | $134 |
| E.R. Squibb & Sons, L.L.C. | 5 | $117 |
| Bausch Health US, LLC | 3 | $81 |
| Supernus Pharmaceuticals, Inc. | 4 | $78 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $70 |
Products named: VRAYLAR, CAPLYTA, LOREEV XR, REXULTI, Auvelity, COBENFY, FANAPT, HETLIOZ.
Industry payments across FL — which companies pay providers there.
